World of Bacteria header image

Pseudomonas aeruginosa

Pseudomonas aeruginosa is an oxidase-positive, non-fermenting Gram-negative rod widely distributed in moist environments and notable for green pigment production, biofilm formation, opportunistic infections, and extensive intrinsic and acquired antimicrobial resistance.

Basic Characteristics

Taxonomy

  • Domain: Bacteria
  • Phylum: Pseudomonadota (Proteobacteria)
  • Class: Gammaproteobacteria
  • Order: Pseudomonadales
  • Family: Pseudomonadaceae
  • Genus: Pseudomonas
  • Species: Pseudomonas aeruginosa

Microscopy & Gram Stain

  • Slender Gram-negative rods
  • Cells usually occur singly or in pairs
  • Motile by means of polar flagella; microscopic morphology is not species-specific

Oxygen Relationship

  • Primarily aerobic and non-fermenting
  • Can grow anaerobically when suitable alternative electron acceptors, such as nitrate, are available

Rapid Identification Tests

  • Oxidase: positive
  • Catalase: positive
  • Glucose metabolism: oxidative, non-fermentative
  • Motility: positive
  • Growth at 42 °C: usually positive
  • Pigments: pyocyanin and pyoverdine may produce blue-green to yellow-green coloration

Ecology and Clinical Relevance

Natural Habitat

  • Soil, freshwater, wastewater, and other moist environmental habitats
  • Hospital water systems, sinks, drains, and wet equipment
  • Plant, animal, and human-associated moist surfaces
  • May transiently colonize the skin, respiratory tract, gastrointestinal tract, or other body sites

Common Clinical Specimens

  • Respiratory specimens, including material from ventilated patients and people with cystic fibrosis
  • Wound, burn, and soft-tissue specimens
  • Urine and catheter-associated urinary specimens
  • Blood cultures
  • Ear, eye, and other localized specimens

Clinical Significance

  • Important opportunistic and healthcare-associated pathogen
  • Associated with pneumonia, bloodstream infection, urinary tract infection, surgical-site infection, and device-related infection
  • A major cause of chronic respiratory colonization and infection in cystic fibrosis and other structural lung diseases
  • Biofilm formation promotes persistence on tissues, medical devices, and moist environmental surfaces

Differential Considerations

  • Stenotrophomonas maltophilia, Achromobacter xylosoxidans, and Acinetobacter baumannii
  • Other fluorescent and non-fluorescent Pseudomonas species
  • Aeromonas and Vibrio species, which are oxidase-positive but ferment glucose
  • Helpful preliminary clues include oxidase positivity, non-fermentative metabolism, growth at 42 °C, characteristic pigments, and growth on cetrimide agar

Diagnostic and Clinical Notes

Pseudomonas aeruginosa is widely distributed in water, soil, and other moist habitats and is especially well adapted to persist in healthcare water systems, sinks, drains, respiratory equipment, and other wet environmental reservoirs.

Pigment production is one of the most recognizable laboratory features. Blue-green pyocyanin is strongly associated with P. aeruginosa, while fluorescent yellow-green pyoverdine is produced by this and several other fluorescent pseudomonads. Pigmentation varies between isolates, and some clinically important strains may appear weakly pigmented or non-pigmented.

Cetrimide agar is useful as a selective and pigment-enhancing medium. Growth with characteristic coloration provides a valuable presumptive clue, but definitive identification should integrate oxidase activity, non-fermentative metabolism, temperature tolerance, and an instrumental or molecular identification method.

Biofilm formation contributes to persistent colonization of medical devices, chronic wounds, and the respiratory tract. In cystic fibrosis and other chronic lung diseases, long-term adaptation may produce mucoid variants with abundant alginate and altered colony morphology.

Clinical interpretation depends on the specimen and host. Recovery may represent colonization, particularly from non-sterile respiratory or device-associated material, but isolation from blood or compatible invasive specimens is clinically significant and requires prompt susceptibility testing.

Laboratory Identification

Colony Morphology

On routine agar after approximately 18–24 hours at 35–37 °C, Pseudomonas aeruginosa commonly forms medium-sized to large, flat or slightly raised colonies that may show irregular margins, metallic sheen, beta-haemolysis, and blue-green, yellow-green, or occasionally brown pigmentation. Colony morphology and pigment intensity vary considerably between strains.

Microscopy

Gram staining shows slender Gram-negative rods occurring mainly singly or in pairs. The morphology is compatible with a non-fermenting Gram-negative bacillus but does not permit species identification.

Key Identification Clues

  • Slender Gram-negative, motile rod
  • Oxidase and catalase positive
  • Non-fermentative oxidative metabolism
  • Usually capable of growth at 42 °C
  • Pyocyanin and pyoverdine may produce blue-green to fluorescent yellow-green coloration
  • Growth on cetrimide agar with enhanced pigment production
  • Strong biofilm-forming capacity; mucoid variants may occur in chronic respiratory infection

Modern Identification Methods

Species identification is commonly achieved by MALDI-TOF mass spectrometry or validated automated biochemical systems. Molecular or genome-based methods may be used for unusual isolates, outbreak investigation, strain typing, and characterization of resistance determinants, including carbapenemase genes.

Antibiotic Characteristics

Pseudomonas aeruginosa has substantial intrinsic resistance because of low outer-membrane permeability, active multidrug efflux pumps, chromosomal AmpC beta-lactamase, and the protective effects of biofilm growth.

Additional resistance may arise through porin loss or modification, target mutations, increased efflux or AmpC expression, aminoglycoside resistance mechanisms, and acquisition of carbapenemases such as VIM, IMP, or NDM enzymes.

Multidrug-resistant and carbapenem-resistant isolates are important healthcare-associated threats and may leave very limited therapeutic options. Resistance patterns vary considerably between institutions, patient populations, and individual strains.

Note: Clinically significant isolates should undergo antimicrobial susceptibility testing using a validated method. Antimicrobial selection must be based on the individual result, infection site, severity, and clinical context rather than on colony colour or another phenotypic feature.

External Resources

For broader information about Pseudomonas aeruginosa, environmental persistence, human infection, laboratory identification, antimicrobial resistance, and current taxonomy, see: